Latest
Govineer Solutions Lands TA Investment as AI Targets Local Government InfrastructureGovineer Solutions Lands TA Investment as AI Targets Local Government Infrastructure|9amHealth Raises $26M Series B as Chronic Care Economics Shift9amHealth Raises $26M Series B as Chronic Care Economics Shift|QuartzBio Secures Eir Partners Investment to Expand Clinical Trial IntelligenceQuartzBio Secures Eir Partners Investment to Expand Clinical Trial Intelligence|Oishii Raises $150M Series C as Vertical Farming Grows Up FastOishii Raises $150M Series C as Vertical Farming Grows Up Fast|DataMission.ai Raises $1M Seed to Modernize the Software Layer Running Local GovernmentDataMission.ai Raises $1M Seed to Modernize the Software Layer Running Local Government|Monaco Raises $50M Series B as AI Sales Infrastructure Gets Rebuilt From ScratchMonaco Raises $50M Series B as AI Sales Infrastructure Gets Rebuilt From Scratch|cultivate(MD) Deploys Capital Across 4 Medtech Companies as Precision Medicine Infrastructure Acceleratescultivate(MD) Deploys Capital Across 4 Medtech Companies as Precision Medicine Infrastructure Accelerates|Anduril Industries Raises $5B Series H as Defense Tech Enters Its Factory EraAnduril Industries Raises $5B Series H as Defense Tech Enters Its Factory Era|Top Down Ventures Closes $28M Fund I as MSP Software Quietly Becomes Venture Capital’s Most Underestimated Infrastructure BetTop Down Ventures Closes $28M Fund I as MSP Software Quietly Becomes Venture Capital’s Most Underestimated Infrastructure Bet|EnsoData Secures Growth Capital as Sleep Medicine Becomes an Infrastructure ProblemEnsoData Secures Growth Capital as Sleep Medicine Becomes an Infrastructure Problem|Govineer Solutions Lands TA Investment as AI Targets Local Government InfrastructureGovineer Solutions Lands TA Investment as AI Targets Local Government Infrastructure|9amHealth Raises $26M Series B as Chronic Care Economics Shift9amHealth Raises $26M Series B as Chronic Care Economics Shift|QuartzBio Secures Eir Partners Investment to Expand Clinical Trial IntelligenceQuartzBio Secures Eir Partners Investment to Expand Clinical Trial Intelligence|Oishii Raises $150M Series C as Vertical Farming Grows Up FastOishii Raises $150M Series C as Vertical Farming Grows Up Fast|DataMission.ai Raises $1M Seed to Modernize the Software Layer Running Local GovernmentDataMission.ai Raises $1M Seed to Modernize the Software Layer Running Local Government|Monaco Raises $50M Series B as AI Sales Infrastructure Gets Rebuilt From ScratchMonaco Raises $50M Series B as AI Sales Infrastructure Gets Rebuilt From Scratch|cultivate(MD) Deploys Capital Across 4 Medtech Companies as Precision Medicine Infrastructure Acceleratescultivate(MD) Deploys Capital Across 4 Medtech Companies as Precision Medicine Infrastructure Accelerates|Anduril Industries Raises $5B Series H as Defense Tech Enters Its Factory EraAnduril Industries Raises $5B Series H as Defense Tech Enters Its Factory Era|Top Down Ventures Closes $28M Fund I as MSP Software Quietly Becomes Venture Capital’s Most Underestimated Infrastructure BetTop Down Ventures Closes $28M Fund I as MSP Software Quietly Becomes Venture Capital’s Most Underestimated Infrastructure Bet|EnsoData Secures Growth Capital as Sleep Medicine Becomes an Infrastructure ProblemEnsoData Secures Growth Capital as Sleep Medicine Becomes an Infrastructure Problem
Back to articles

AnD Ventures

Most firms enter the startup ecosystem with distance. AnD Ventures closes that distance fast. In Tel Aviv, where early-stage companies are forged under pressure, the firm operates inside the build, not adjacent to it. Founders do not experience them as passive capital. They experience them in the decisions that determine whether a product survives first contact with the market.

Led by Managing Partners Lee Moser and Roy Geva Glasberg, AnD Ventures brings operator gravity to early-stage investing. The verified team includes Mandy Rotner, CFO, Ron Porat, CTO, Dalit Krainer, Head of People & Strategic Growth, Noy Dan, Studio Director, Danielle Zettel, Director Investor Relations & Communications, Matan Malka, Assistant Controller, and Paz Lazar, Chief of Staff. That lineup matters because the firm is not selling founder therapy with nicer fonts. It is building a bench around finance, technology, people, studio execution, investor relations, and operations.

AnD Ventures backs early-stage Israeli startups, often with initial revenue already moving, then embeds where the company is most exposed. Product market fit gets pressure-tested. Go-to-market becomes a system. Strategic partnerships become part of the operating plan. Their focus sits on data, AI, cutting-edge technologies, and validated market fit. In a startup ecosystem increasingly defined by proof over pitch, that filter separates builders with market heat from founders still negotiating with a slide deck.

In 2023, AnD Ventures closed a $70M fund, exceeding its original $50M target, with capital from U.S.-based venture capital fund managers, private equity managers, and hedge fund managers. That is not just a fundraising note. It is a market signal. LPs backed a model built around early revenue, hands-on company building, and a clear belief that Israeli technical talent still has global room to run.

The firm describes its team as product managers, CTOs, founders, financial advisors, and cybersecurity experts working with growth partners from Fortune 500 companies, serial entrepreneurs, innovators, and industry experts. Strip away the polite VC language and the point is simple. Early companies die in the gaps between product, customer, capital, and execution. AnD Ventures is designed to close those gaps before the market punishes them.

That is the AnD in AnD Ventures. Capital and company building. Conviction and validation. Local density and global ambition. The firm’s portfolio companies are in build mode, and operators who want proximity to early-stage momentum should pay attention.

Follow this firm. Study their founders. Track their plays.